Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors

Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors

Abstract Background Circulating tumor DNA (ctDNA) offers a convenient way to monitor tumor progression and treatment response. Because tumor mutational profiles are highly variable from person to person, a fixed content panel may be insufficient to track treatment response in all patients. Methods W...

Full description

Bibliographic Details
Main Authors: Jiaping Li, Wei Jiang, Jinwang Wei, Jianwei Zhang, Linbo Cai, Minjie Luo, Zhan Wang, Wending Sun, Shengzhou Wang, Chen Wang, Chun Dai, Jun Liu, Guan Wang, Jiping Wang, Qiang Xu, Yanhong Deng
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Journal of Translational Medicine
Subjects:
Customized ctDNA panel
ctDNA fingerprint
Cancer treatment response
Whole exome sequencing
Drug-related mutation
Online Access:http://link.springer.com/article/10.1186/s12967-020-02449-y

Internet

http://link.springer.com/article/10.1186/s12967-020-02449-y

Similar Items